IP Library Granted Patent US 9,186,352
Granted Patent B2
US 9,186,352 · App. 14/168,571 · Granted Nov 17, 2015

Chemical compositions for enhancing transdermal delivery of therapeutic agents

Inventors: Kirti H. Valia (Plainsboro, NJ); Agis Kydonieus (Kendall Park, NJ)
Assignee: InteguRx Therapeutics, LLC
A61K31/4178A61K9/0014A61K9/08A61K31/439A61K31/46A61K31/4709A61K47/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,352
App. No.
14/168,571
Granted
Nov 17, 2015
Kind
B2
Abstract

The present application discloses chemical compositions and methods for enhancing the transdermal permeation of therapeutic agents through skin. The chemical compositions and methods of the invention can include combinations of a first fatty acid having about 14 or more carbon atoms and a second fatty acid having about 10 or less carbon atoms. These compositions are useful for the delivery of therapeutic agents, in particular hard to deliver drugs such as those that have fused rings, including ondansetron, and large drugs such as peptides. The compositions of the invention can be formulated as transdermal gels, lotions, creams, transdermal patches, sprays or mists.

Claims (19)

1. A composition for use on human skin comprising:

a mixture comprising

ondansetron, an ondansetron salt, or a mixture thereof;

from about 1% to about 5% by weight of the composition of oleic acid; and

from about 1% to about 5% by weight of the composition of levulinic acid.

2. The composition of claim 1 , comprising ondansetron.

3. The composition of claim 1 , comprising an ondansetron salt.

4. The composition of claim 3 , wherein the ondansetron salt is ondanstron hydrochloride.

5. The composition of claim 1 , comprising oleic acid.

6. The composition of claim 1 comprising ondansetron and an ondansetron salt.

7. A transdermal patch for use on human skin comprising

a mixture comprising

ondansetron, an ondansetron salt, or a mixture thereof;

from about 1% to about 5% by weight of the mixture of oleic acid; and

from about 1% to about 5% by weight of the mixture of levulinic acid.

8. The transdermal patch of claim 7 , comprising ondansetron.

9. The transdermal patch of claim 7 , comprising an ondansetron salt.

10. The transdermal patch of claim 9 , wherein the ondansetron salt is ondanstron hydrochloride.

11. The transdermal patch of claim 7 comprising ondansetron and an ondansetron salt.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2014
From: VALIA, KIRTI H.; KYDONIEUS, AGIS
To: INTEGURX THERAPEUTICS, LLC
Reel/Frame 034298/0846 →
Continuity (4)
Continuation PCTUS2013056391 · Aug 23, 2013
Provisional Application 61693135 · Aug 24, 2012
Provisional Application 61777276 · Mar 12, 2013
Related Publication 20140148491A1 · May 29, 2014